Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis

Published:2020-09-30 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Luo Yi,Jiang Hongyi,Xu Weibo,Wang Xiao,Ma Ben,Liao Tian,Wang Yu

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference52 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer.,2019

2. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis;Liu;J Surg Oncol.,2015

3. Definition and management of radioactive iodine-refractory differentiated thyroid cancer;Schlumberger;Lancet Diabetes Endocrinol.,2014

4. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy;Durante;J Clin Endocrinol Metab.,2006

5. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer;Haugen;Thyroid,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors;Hormones;2024-09-03

2. Analyzing the correlation between low proportion of hobnail features in papillary thyroid carcinoma and clinical aggressiveness risk;Endocrine;2024-07-06

3. Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma;World Journal of Nuclear Medicine;2024-06-14

4. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30

5. Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status;Journal of Endocrinological Investigation;2024-04-05